On November 18, 2024, Marcela Maus, a Director at 2seventy bio Inc (TSVT, Financial), sold 3,900 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 23,752 shares of the company.
2seventy bio Inc (TSVT) is a biotechnology company focused on the development of innovative therapies for cancer treatment. The company aims to deliver transformative therapies to patients by leveraging its expertise in cell and gene therapy.
The insider transaction history for 2seventy bio Inc shows that there have been 2 insider buys and 16 insider sells over the past year. This indicates a trend of more selling activity among insiders.
On the day of the recent sell by Marcela Maus, shares of 2seventy bio Inc were trading at $3.38, giving the stock a market cap of $160.439 million. The stock's GF Value is estimated at $3.94, resulting in a price-to-GF-Value ratio of 0.86, suggesting that the stock is modestly undervalued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
